YOLFTbeta
00

Jilin Jian Yisheng Pharmaceutical Co Ltd

002566 · SHE · Healthcare / Biotechnology

5.97CNY-0.07 (-1.16%)

Price History

Full chart

Market Stats

Previous Close6.04
Open6.08
Day Range5.94 – 6.08
52-Week Range5.76 – 9.57
Volume3.92M
Market Cap2.34B
P/E (TTM)64.18
Forward P/E24.75
EPS0.11
Dividend Yield1.13%
Beta0.15
50-Day Avg6.81
200-Day Avg7.46

About

Jilin Jian Yisheng Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, wholesale, retail, import, and export of pharmaceutical products in China. The company offers drugs comprising capsules, injections, tablets, granules, and other drug products; cosmetics; ginseng products; bee products; and food products comprising acai collagen solid drinks, multivitamin mineral tablets, collagen peptide juice drinks, and fruit lemon powder. It is also involved in pharmaceutical contract manufacturing; production of health food, food, health care products; special medical products; production of fertilizers and beverages; sale of food through the internet; planting and production of Chinese medicinal herbs extracts; wholesale and retail of cosmetics; road freight transportation; research and development of bio-organic and microbial fertilizers; non-residential real estate, machinery, and equipment leasing; packaging printing; paper cutting and sales; development and application of human stem cell technology; and the traditional spice products business. In addition, the company provides life beauty services; Chinese medicine health and wellness services; and technical development, consulting, exchange, promotion, and transfer services. Jilin Jian Yisheng Pharmaceutical Co., Ltd. was founded in 1997 and is headquartered in Ji'an, China.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Xiaomin Xue
  • Employees1.66K
  • HeadquartersNo. 17-20 Wenhua East Road, Ji'an, China, 134200, China
  • Websitehttps://yisheng-pharm.com

Leadership

  • Mr. Xiaomin XueGeneral Manager · b. 1958
  • Mr. Jian Tao BiDeputy GM, CFO & Non-Independent Director · b. 1970
  • Mr. Tiejun LiDeputy GM & Secretary of the Board · b. 1960
  • Mr. Wei MengDeputy General Manager · b. 1973
  • Meihua SuAccounting Supervisor

Financials

Income Statement

Currency: CNY2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue226.37M267.84M311.75M414.88M516.22M528.93M600.50M643.90M787.89M819.60M939.01M1.03B975.09M1.01B842.59M877.93M830.04M853.66M668.47M640.17M
Growth (%)-+18.32%+16.40%+33.08%+24.43%+2.46%+13.53%+7.23%+22.36%+4.02%+14.57%+10.16%-5.74%+3.86%-16.80%+4.19%-5.45%+2.85%-21.69%-4.23%
Cost of Revenue64.87M69.73M73.86M104.51M124.96M134.40M184.42M170.32M254.11M228.99M279.77M286.11M238.91M259.97M217.11M221.22M215.44M224.80M174.13M166.50M
Gross Profit161.50M198.11M237.89M310.38M391.27M394.52M416.08M473.58M533.78M590.61M659.24M748.34M736.17M752.78M625.48M656.71M614.60M628.87M494.34M473.67M
Gross Margin71.34%73.96%76.31%74.81%75.79%74.59%69.29%73.55%67.75%72.06%70.21%72.34%75.50%74.33%74.23%74.80%74.04%73.67%73.95%73.99%
Operating Expense127.58M151.66M187.69M243.31M293.06M287.23M345.18M411.31M435.38M586.92M651.20M647.31M629.48M641.78M515.74M528.07M511.94M513.14M432.98M434.84M
Operating Income33.92M46.44M50.20M67.07M98.21M107.29M70.90M62.27M98.41M3.69M8.04M101.03M106.70M111.00M109.74M128.63M102.66M115.73M61.36M38.84M
Operating Margin14.98%17.34%16.10%16.17%19.02%20.28%11.81%9.67%12.49%0.45%0.86%9.77%10.94%10.96%13.02%14.65%12.37%13.56%9.18%6.07%
EBITDA38.56M53.97M65.54M82.46M119.37M131.72M138.13M121.46M146.40M80.47M96.60M165.36M162.98M167.57M159.11M177.19M155.44M170.75M116.14M85.38M
EBITDA Margin17.03%20.15%21.02%19.88%23.12%24.90%23.00%18.86%18.58%9.82%10.29%15.99%16.71%16.55%18.88%20.18%18.73%20.00%17.37%13.34%
Net Income23.47M36.11M41.37M61.13M87.64M96.48M96.63M87.32M96.41M10.91M13.19M60.07M69.08M76.60M80.06M96.02M83.10M94.73M52.09M29.00M
Net Income Margin10.37%13.48%13.27%14.73%16.98%18.24%16.09%13.56%12.24%1.33%1.41%5.81%7.08%7.56%9.50%10.94%10.01%11.10%7.79%4.53%
R&D5.95M6.38M7.57M---22.55M28.64M27.79M31.68M17.53M33.44M35.02M35.50M33.23M20.89M18.78M18.68M16.22M15.14M
R&D as % of Total Revenue2.63%2.38%2.43%---3.76%4.45%3.53%3.87%1.87%3.23%3.59%3.51%3.94%2.38%2.26%2.19%2.43%2.36%
Interest Expense172.41K4.16M4.72M2.15M1.13M651.71K1.91M419.37K12.88M41.08M35.29M27.97M22.64M17.01M13.40M13.54M14.12M13.78M13.98M12.62M
Interest Expense % of Total Revenue0.08%1.55%1.51%0.52%0.22%0.12%0.32%0.07%1.64%5.01%3.76%2.70%2.32%1.68%1.59%1.54%1.70%1.61%2.09%1.97%

Balance Sheet

Currency: CNY2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets338.04M341.67M347.32M427.66M515.06M1.58B1.66B1.89B2.49B2.63B2.67B2.65B2.55B2.50B2.80B2.86B2.97B3.05B2.97B2.96B
Total Liabilities99.35M136.08M127.43M146.67M155.66M64.52M72.81M213.79M739.24M888.65M869.67M756.40M587.49M438.66M663.86M666.08M717.18M714.30M637.22M630.35M
Total Equity238.69M204.84M219.15M280.28M358.72M1.49B1.57B1.66B1.73B1.72B1.74B1.80B1.86B1.93B2.00B2.08B2.15B2.23B2.24B2.23B
Cash29.18M54.53M23.33M47.14M46.18M883.87M850.61M398.05M312.13M161.80M79.89M80.59M38.84M63.01M287.00M219.70M343.26M487.73M71.48M63.55M
Total Debt66.77M78.77M79.77M28.02M43.89M5.01M3.88M102.75M482.37M761.99M711.61M541.23M440.85M293.02M417.95M415.18M443.55M474.46M446.19M-
Net Debt37.59M24.24M56.44M-19.12M-2.29M-878.86M-846.73M-295.30M170.24M600.19M631.72M460.64M402.01M230.01M130.96M195.49M100.28M-11.37M374.71M354.37M

Cash Flow

Currency: CNY2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow25.58M82.66M20.50M125.25M50.73M-112.12M79.08M-188.45M-592.06M-324.29M-17.52M270.65M167.32M210.87M203.51M215.10M145.86M209.13M58.94M98.74M
Investing Cash Flow-17.73M-11.03M-11.90M-42.41M-56.84M-44.08M-87.23M-362.56M159.95M-51.51M-21.19M-87.47M-69.48M-21.63M-75.84M-207.06M1.77M-73.39M-375.21M-
Financing Cash Flow-4.85M-46.28M-39.79M-59.03M5.16M993.89M-25.10M98.45M346.19M225.48M-43.20M-182.48M-139.58M-165.07M96.31M-75.34M-24.06M8.73M-99.99M-
Capital Expenditure17.75M11.42M11.98M42.41M48.89M44.43M87.54M72.36M68.50M102.25M54.41M83.49M73.72M21.70M75.93M107.07M41.36M35.77M15.94M13.64M
Free Cash Flow7.84M71.24M8.52M82.84M1.83M-156.55M-8.46M-260.81M-660.56M-426.54M-71.93M187.16M93.59M189.18M127.58M108.04M104.49M173.36M43.00M85.10M
Dividends Paid2.85M59.03M40.79M7.28M10.71M651.71K22.19M419.37K33.43M55.89M35.25M28.20M39.20M17.24M16.55M9.93M9.93M29.86M61.64M45.61M
FCF to OCF30.64%86.19%41.56%66.14%3.61%139.63%-10.70%138.39%111.57%131.53%410.49%69.15%55.94%89.71%62.69%50.23%71.64%82.89%72.95%86.19%
Dividend Paid to FCF36.30%82.85%478.84%8.79%585.11%-0.42%-262.30%-0.16%-5.06%-13.10%-49.01%15.07%41.89%9.11%12.97%9.19%9.50%17.22%143.33%53.59%

Earnings

Report DateAug 18, 2014Oct 24, 2014Feb 10, 2015Apr 29, 2015Aug 10, 2015Oct 27, 2015Dec 31, 2015Apr 26, 2016Aug 23, 2016Oct 25, 2016Mar 6, 2017Apr 28, 2017Aug 23, 2017Oct 24, 2017Dec 31, 2017Apr 21, 2018Aug 22, 2018Oct 19, 2018Dec 31, 2018Apr 16, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Apr 25, 2020Aug 18, 2020Oct 24, 2020Dec 31, 2020Apr 28, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023May 10, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024May 9, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate0.100.080.09-0.120.10-0.120.160.230.00----0.000.000.00-------------------------------
EPS Actual0.100.060.090.040.130.05-0.18-0.180.040.02-0.050.060.030.040.05-0.05-0.05-0.050.050.050.070.050.060.060.030.060.080.080.040.070.090.080.050.050.070.090.060.030.110.060.040.010.050.040.020.020.010.050.03
Surprise0.00%-25.00%0.00%-8.33%-50.00%--250.00%-75.00%-91.30%---------------------------------------
TimingAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-market-Pre-marketAfter-hoursPre-marketPre-market-After-hoursPre-market-Pre-marketAfter-hoursPre-market-Pre-market-------------------After-hours---After-hours-----

Key Statistics & Ratios

Market Cap2.34B
Enterprise Value2.16B
Trailing P/E64.18
Forward P/E24.75
PEG Ratio0.00
Price / Sales3.59
Price / Book1.04
EPS0.11
Book Value6.74
Revenue (TTM)650.83M
Gross Profit (TTM)477.18M
EBITDA49.37M
Profit Margin5.70%
Operating Margin2.89%
Return on Equity1.59%
Return on Assets0.25%
Shares Outstanding330.95M
Shares Float187.23M
Beta0.15
Dividend Yield1.13%
Dividend Rate0.08
Payout Ratio71.43%

Dividends

20261×
0.08May 29, 2026
20251×
0.10May 22, 2025
20241×
0.15May 22, 2024
20231×
0.05Jul 7, 2023
20221×
0.03Jul 7, 2022
20211×
0.03May 18, 2021
20201×
0.05Jun 16, 2020
20181×
0.05Jun 28, 2018
20151×
0.05Jun 26, 2015
20141×
0.10May 22, 2014
20121×
0.07Apr 18, 2012

Stock Splits

  • May 22, 201415:10
  • Apr 18, 201220:10